ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 179945 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 179945; 2) Community: the network communities that were significantly associated with the response to NSC 179945; 3) Molecule: the relationships between components within communities and NSC 179945; 4) MDR: the compounds that were significantly associated with the NSC 179945.

NSC Compound Enrichment Correlation
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0352383000003052 0.44658804
NSC 681104 Phosphonic acid, [1,4,7,10-tetraazacyclododecane-1,7-diylbis(methylene)]bis- 0.0352383000003052 0.14618987
NSC 717189 Null 0.0352383000003052 0.21636762
NSC 747180 Null 0.0352383000003052 -0.041548029
NSC 100880 Camptothecin 0.0352383000003056 -0.069579822
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0352383000003056 0.07071493
NSC 144126 Null 0.0352383000003056 0.28713149
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0352383000003058 0.27240891
NSC 303812 Aphidicoline glycinate 0.0352383000003058 0.030349781
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0352383000003058 0.60146089
Total:71  Current:45    [First] [Prev] [Next] [Last]